These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2668713)

  • 1. [Inhibition of pancreatic beta-cell secretion during "glucose clamp" in patients with polycystic ovary syndrome].
    Randazzo C; Mistretta A; Pugliese A; Sinagra D
    Minerva Endocrinol; 1989; 14(2):109-13. PubMed ID: 2668713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibition of pancreatic beta-cell secretion during a "glucose-clamp" in subjects with acanthosis nigricans].
    Sinagra D; Randazzo C; Mistretta A; Pugliese A
    Minerva Med; 1989 Mar; 80(3):233-5. PubMed ID: 2654759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity in beta cell activity, hepatic insulin clearance and peripheral insulin sensitivity in women with polycystic ovary syndrome.
    Ciampelli M; Fulghesu AM; Cucinelli F; Pavone V; Caruso A; Mancuso S; Lanzone A
    Hum Reprod; 1997 Sep; 12(9):1897-901. PubMed ID: 9363702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preserved insulin sensitivity and {beta}-cell activity, but decreased glucose effectiveness in normal-weight women with the polycystic ovary syndrome.
    Gennarelli G; Rovei V; Novi RF; Holte J; Bongioanni F; Revelli A; Pacini G; Cavallo-Perin P; Massobrio M
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3381-6. PubMed ID: 15755857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin, C-peptide, androgens, and beta-endorphin response to oral glucose in patients with polycystic ovary syndrome.
    Tropeano G; Lucisano A; Liberale I; Barini A; Vuolo IP; Martino G; Menini E; Dell'Acqua S
    J Clin Endocrinol Metab; 1994 Feb; 78(2):305-9. PubMed ID: 8106616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperinsulinism and polycystic ovary syndrome (PCOS): role of insulin clearance.
    Amato MC; Vesco R; Vigneri E; Ciresi A; Giordano C
    J Endocrinol Invest; 2015 Dec; 38(12):1319-26. PubMed ID: 26294351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired beta-cell compensation to dexamethasone-induced hyperglycemia in women with polycystic ovary syndrome.
    Ehrmann DA; Breda E; Corcoran MC; Cavaghan MK; Imperial J; Toffolo G; Cobelli C; Polonsky KS
    Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E241-6. PubMed ID: 14665448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and beta-cell dysfunction and risk of cardiovascular disease.
    Arslanian SA; Lewy VD; Danadian K
    J Clin Endocrinol Metab; 2001 Jan; 86(1):66-71. PubMed ID: 11231980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular risk in young women with polycystic ovary and polycystic ovary syndrome.
    Battaglia C; Mancini F; Cianciosi A; Busacchi P; Facchinetti F; Marchesini GR; Marzocchi R; de Aloysio D
    Obstet Gynecol; 2008 Feb; 111(2 Pt 1):385-95. PubMed ID: 18238977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance but not impaired β-cell function: a key feature in Chinese normal-weight PCOS women with normal glucose regulation.
    Li W; Ma L; Li Q
    Gynecol Endocrinol; 2012 Aug; 28(8):598-601. PubMed ID: 22309514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
    Svendsen PF; Nilas L; Madsbad S; Holst JJ
    Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of insulin resistance in lean women with polycystic ovary syndrome.
    Morciano A; Romani F; Sagnella F; Scarinci E; Palla C; Moro F; Tropea A; Policola C; Della Casa S; Guido M; Lanzone A; Apa R
    Fertil Steril; 2014 Jul; 102(1):250-256.e3. PubMed ID: 24825420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic beta cell function in polycystic ovary syndrome: its relationship to body weight, serum testosterone and serum prolactin levels.
    Prelević GM; Würzburger MI; Perić LA
    Exp Clin Endocrinol; 1987 Aug; 90(1):76-82. PubMed ID: 3311782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance according to β-cell function in women with polycystic ovary syndrome and normal glucose tolerance.
    Song DK; Hong YS; Sung YA; Lee H
    PLoS One; 2017; 12(5):e0178120. PubMed ID: 28542421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance in nonobese patients with polycystic ovary syndrome.
    Toprak S; Yönem A; Cakir B; Güler S; Azal O; Ozata M; Corakçi A
    Horm Res; 2001; 55(2):65-70. PubMed ID: 11509861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and possible mechanisms of reactive hypoglycemia in polycystic ovary syndrome.
    Mumm H; Altinok ML; Henriksen JE; Ravn P; Glintborg D; Andersen M
    Hum Reprod; 2016 May; 31(5):1105-12. PubMed ID: 27008892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The link between metabolic features and TSH levels in polycystic ovary syndrome is modulated by the body weight: an euglycaemic-hyperinsulinaemic clamp study.
    Tagliaferri V; Romualdi D; Guido M; Mancini A; De Cicco S; Di Florio C; Immediata V; Di Segni C; Lanzone A
    Eur J Endocrinol; 2016 Nov; 175(5):433-41. PubMed ID: 27511825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of hypo- and hyperglycaemia on plasma leptin concentrations in healthy women and in women with polycystic ovary syndrome.
    Ludwig AK; Weiss JM; Tauchert S; Dietze T; Rudolf S; Diedrich K; Peters A; Oltmanns KM
    Hum Reprod; 2007 Jun; 22(6):1555-61. PubMed ID: 17395684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose intolerance in Japanese patients with polycystic ovary syndrome.
    Kurioka H; Takahashi K; Miyazaki K
    Arch Gynecol Obstet; 2007 Mar; 275(3):169-73. PubMed ID: 16972071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment.
    Ciaraldi TP; Aroda V; Mudaliar SR; Henry RR
    Metabolism; 2013 Nov; 62(11):1587-96. PubMed ID: 23958241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.